These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 21258130

  • 1. Optional screening strategies for cervical cancer using standalone tests and their combinations among low- and medium-income populations in Latin America and Eastern Europe.
    Sarian LO, Derchain S, Shabalova I, Tatti S, Naud P, Longatto-Filho A, Syrjänen S, Syrjänen K, members of the Latin American Screening Study (LAMS), New Independent States of the Former Soviet Union (NIS) groups.
    J Med Screen; 2010; 17(4):195-203. PubMed ID: 21258130
    [Abstract] [Full Text] [Related]

  • 2. Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and > or =35 years of age: experience from the Latin American Screening Study.
    Syrjänen K, Derchain S, Roteli-Martins C, Longatto-Filho A, Hammes LS, Sarian L, Latin American Screening Study Group.
    Acta Cytol; 2008; 52(6):641-53. PubMed ID: 19068666
    [Abstract] [Full Text] [Related]

  • 3. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G, Nyaga VN, Santesso N, Bryant A, Martin-Hirsch PP, Mustafa RA, Schünemann H, Paraskevaidis E, Arbyn M.
    Cochrane Database Syst Rev; 2017 Aug 10; 8(8):CD008587. PubMed ID: 28796882
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
    Sarian LO, Derchain SF, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo R, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.
    J Med Screen; 2005 Aug 10; 12(3):142-9. PubMed ID: 16156945
    [Abstract] [Full Text] [Related]

  • 7. Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.
    Derchain SF, Sarian LO, Naud P, Roteli-Martins C, Longatto-Filho A, Tatti S, Branca M, Erzen M, Serpa-Hammes L, Matos J, Gontijo RC, Bragança JF, Lima TP, Maeda MY, Lörincz A, Dores GB, Costa S, Syrjänen S, Syrjänen K.
    J Med Screen; 2008 Aug 10; 15(2):97-104. PubMed ID: 18573778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?
    Ferris DG, Wright TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.
    J Fam Pract; 1998 Feb 10; 46(2):125-34. PubMed ID: 9487318
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New concepts on risk factors of HPV and novel screening strategies for cervical cancer precursors.
    Syrjänen K.
    Eur J Gynaecol Oncol; 2008 Feb 10; 29(3):205-21. PubMed ID: 18592782
    [Abstract] [Full Text] [Related]

  • 13. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.
    Monsonego J, Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E.
    Int J Gynecol Cancer; 2006 Feb 10; 16(2):591-8. PubMed ID: 16681731
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.
    JAMA; 2002 Oct 09; 288(14):1749-57. PubMed ID: 12365959
    [Abstract] [Full Text] [Related]

  • 18. Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer.
    Costa S, Sideri M, Syrjänen K, Terzano P, De Nuzzo M, De Simone P, Cristiani P, Finarelli AC, Bovicelli A, Zamparelli A, Bovicelli L.
    Acta Cytol; 2000 Oct 09; 44(3):310-8. PubMed ID: 10833984
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pooled analysis of the accuracy of five cervical cancer screening tests assessed in eleven studies in Africa and India.
    Arbyn M, Sankaranarayanan R, Muwonge R, Keita N, Dolo A, Mbalawa CG, Nouhou H, Sakande B, Wesley R, Somanathan T, Sharma A, Shastri S, Basu P.
    Int J Cancer; 2008 Jul 01; 123(1):153-60. PubMed ID: 18404671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.